CFClovis De Carvalho Frimm

Clovis De Carvalho Frimm

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Clovis De Carvalho Frimm has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Marcia Kiyomi Koike

    Faculdade de Medicina da Universidade de São Paulo, Brasil; Instituto de Assistência Médica ao Servidor Público Estadual de São Paulo, Brasil

    4 shared publications
  • Mariana Cúri

    Department of Applied Mathematics and Statistics, Institute of Mathematical and Computational Sciences, University of São Paulo, São Paulo, Brazil

    4 shared publications
  • Valéria Fontenelle Angelim Pereira

    Heart Institute, University of Sao Paulo, Sao Paulo, Brazil

    2 shared publications
  • Ana Clara T. Rodrigues

    Instituto do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo

    1 shared publication
  • Ana Clara Tude Rodrigues

    Heart Institute (InCor),University of São Paulo Medical School, São Paulo, Brazil

    1 shared publication
  • Ana Clara Tudi Rodrigues

    Heart Institute, University of Sao Paulo, Sao Paulo, Brazil

    1 shared publication

Latest Publications

  • LOW CORONARY DRIVING PRESSURE IS ASSOCIATED WITH SUBENDOCARDIAL REMODELLING AND LEFT VENTRICULAR DYSFUNCTION IN AORTOCAVAL FISTULA

    by Maria C Guido, Clovis De Carvalho Frimm, Márcia K Koike, Fernanda F Cordeiro, Ana Is Moretti, Luiz C Godoy

    SUMMARY: The role of haemodynamic changes in left ventricular remodelling has been poorly investigated, especially in the context of volume overload cardiac hypertrophy. Low diastolic blood pressure and high left ventricular filling pressure are expected to affect coronary driving pressure negatively and thereby put in jeopardy subendocardial perfusion in particular. The consequences to global left ventricular remodelling remain undetermined. The aim of the present study was to investigate the role of coronary driving pressure in the development of subendocardial remodelling and the conceivable effects on cardiac function, using a rat model of aortocaval fistula. Wistar rats, weighing 330–350 g, were submitted to aortocaval fistula (ACF group) or sham (control group) operations. Two haemodynamic measurements were determined following surgery, the initial measurement at week 1 and the final measurement at week 8. Cytokine expression, myeloperoxidase (MPO) activity, metalloproteinase expression and activity and fibrosis were assessed in two distinct left ventricular myocardial layers: the subendocardium (SE) and the non‐subendocardium (non‐SE). The ACF group showed lower initial and final coronary driving pressure and lower final +dP/dt and –dP/dt compared with the control group. Multivariate analyses disclosed initial coronary driving pressure as the only haemodynamic parameter independently associated with SE fibrosis (R2 = 0.76; P < 0.0001) and with +dP/dt (R2 = 0.55; P = 0.0004) and –dP/dt (R2 = 0.91; P < 0.0001). Matrix metalloproteinase (MMP)‐2 expression and activity predominated in the SE of ACF animals, particularly in those with low coronary driving pressure. Increased levels of interleukin (IL)‐6 and IL‐1β also predominated in the SE of the ACF group. Otherwise, MPO activity and levels of tumour necrosis factor‐α and IL‐10 were similar in both groups. Final coronary driving pressure correlated with both the expression and activity of MMP‐2. Low coronary driving pressure early in the course of ACF determines SE damage and, by this mechanism, interferes negatively in left ventricular function.


  • Bradykinin B2 receptor antagonism attenuates inflammation, mast cell infiltration and fibrosis in remote myocardium after infarction in rats

    by Marcia Kiyomi Koike, Clovis De Carvalho Frimm, Maria De Lourdes Higuchi

    Bradykinin may interfere with myocardial remodelling by promoting inflammation and mast cell activation or, alternatively, by counteracting angiotensin II-dependent collagen accumulation. The aim of the present study was to investigate the role of bradykinin B2 receptor antagonism in inflammatory and mast cell infiltration, fibroplasia and fibrosis accumulation following myocardial infarction (MI). Myocardial infarction was produced by the ligature of the left coronary artery in male Wistar rats that were 10 weeks of age. Immediately after MI, rats received the B2 receptor antagonist Hoe140 (0.5 microg/kg per min, s.c.) or saline over a period of 3 days, 1 week or 4 weeks, constituting three separate groups and their respective controls. Coronal myocardial tissue sections underwent haematoxylin and eosin, Giemsa and picrosirius red staining, as well as immunohistochemistry for alpha-smooth muscle actin (SMA). Morphometric studies were undertaken in three different myocardial regions: MI, remote non-infarcted subendocardium (non-MI SE) and remote non-infarcted interventricular septum (non-MI IVS). The MI size was comparable between Hoe140-treated groups and their respective controls (day 3: 42 +/- 4%, n = 8, vs 43 +/- 3%, n = 6; week 1: 37 +/- 5%, n = 5, vs 39 +/- 2%, n = 5; week 4: 35 +/- 3%, n = 9, vs 36 +/- 3%, n = 7). At day 3, Hoe140 treatment reduced inflammatory cell reaction within the MI (585 +/- 59 vs 995 +/- 170 cells/mm2; P = 0.02), non-MI SE (77 +/- 12 vs 214 +/- 57 cells/mm2; P = 0.02) and non-MI IVS (93 +/- 16 vs 135 +/- 14 cells/mm2; P = 0.03) regions. Mast cells were reduced within the non-MI IVS region (0.8 +/- 0.1 vs 2.5 +/- 0.4 cells/mm2; P = 0.006), but not within the MI region. In non-MI SE, mast cells were rarely found. At week 1, Hoe140 treatment reduced alpha-SMA-positive myofibroblast infiltration within the MI (2535 +/- 383 vs 5636 +/- 968 cells/mm2; P = 0.01) and non-MI SE (222 +/- 33 vs 597 +/- 162 cells/mm2; P = 0.03) regions. In the non-MI IVS region, alpha-SMA-positive myofibroblasts were rarely found. At week 4, Hoe140 treatment reduced collagen volume fraction within the MI (37 +/- 4 vs 53 +/- 4%; P = 0.03), non-MI SE (1.3 +/- 0.2 vs 2.6 +/- 0.3%; P = 0.001) and non-MI IVS (1.1 +/- 0.2 vs 1.8 +/- 0.2%; P = 0.01) regions. Bradykinin promotes inflammation, fibroplasia and fibrosis after MI. Mast cells may have a role in fibrosis deposition through a bradykinin-related mechanism.


  • The long-term outcome of patients with hypertensive cardiomyopathy

    by C de Carvalho Frimm, H N Soufen, M K Koike, V F A Pereira, M Cúri

    The prognosis of dilated cardiomyopathy due to hypertension (HT-DCM) is surprisingly unknown, particularly in the absence of coronary disease and diabetes. We aimed at investigating the long-term outcome and the predictors of mortality in patients with left ventricular systolic dysfunction exclusively due to hypertension. From October 1995 to May 2001, 90 consecutive patients with echocardiographic fractional shortening (FS) P=0.01). In HT-DCM, the 5-year mortality rate was 26%. Univariate analyses selected age and creatinine for being positively related to mortality, and body mass index, FS and blood pressure during follow-up for being negatively related to mortality. Neither the improvement of left ventricular FS nor the decrease in left ventricular mass index was related to survival. Multivariate analysis identified (hazard ratio; 95% confidence interval) age (1.08; 1.02–1.13), body mass index (0.86; 0.75–0.98), and baseline FS (0.88; 0.78–0.98) as independent predictors of mortality. In conclusion, poor survival in HT-DCM can be anticipated by the severity of left ventricular systolic dysfunction and advanced age. Instead of ominous signs, high blood pressure and body mass may predict a more favourable prognosis.


  • Open Access

    The imbalance between coronary reserve and wall stress explains the severity of ventricular dysfunction in hypertension

    by Clovis De Carvalho Frimm, Valéria F. A. Pereira, Ana Clara T. Rodrigues, Jeane M. Tsutsui, Mariana Cúri

    Background: The pathophysiologic role of coronary reserve impairment in hypertensive cardiac dysfunction is still debated. Previously, we demonstrated that satisfactory coronary vasodilatation may coexist with ventricular systolic dysfunction. It is conceivable that coronary reserve might otherwise be inappropriate for enhanced myocardial oxygen demand and may thus affect cardiac performance negatively. Hypothesis: Myocardial supply‐demand imbalance contributes to the severity of ventricular dysfunction in hypertension (HTN). Methods: Fractional shortening (%) and end‐systolic stress (103·dyn·cm−2) were determined using echocardiography, and coronary reserve was calculated using trans‐esophageal Doppler echocardiography. Coronary reserve/ stress (cm2·dyn−1) was utilized as a measure of supply‐demand. Groups NL (20 healthy subjects), HTN1 (15 patients, fractional shortening ≥ 30), HTN2 (19 patients, 20 ≤ fractional shortening Results: Compared with NL and HTN1, groups HTN2 and HTN3 had significantly (p < 0.05) greater end‐systolic stress (NL = 72 ± 16, HTN1 = 72 ± 23, HTN2 = 143 ± 32, HTN3 = 186 ± 70). Coronary reserve was impaired in HTN3 alone (NL = 3.5 ± 0.6, HTN1 = 3.4 ± 1.0, HTN2 = 3.1 ± 1.0, HTN3 = 2.6 ±1.1), but coronary reserve/stress was reduced in both HTN2 andHTN3 (NL = 50 ± 12, HTN1 = 53 ± 21, HTN2 = 22 ± 7, HTN3 = 15 ± 7). Stepwise regression analysis identified diastolic internal dimension, end‐systolic stress, and coronary reserve/stress as independently associated with fractional shortening. Conclusion: The imbalance between supply‐demand explains the severity of hypertensive cardiac dysfunction and adds information to cardiac enlargement and elevated wall stress.


  • Open Access

    Subendocardial fibrosis in remote myocardium results from reduction of coronary driving pressure during acute infarction in rats.

    by Clovis de Carvalho Frimm, Marcia Kiyomi Koike, Mariana Cúri

    To investigate the role of hemodynamic changes occurring during acute MI in subsequent fibrosis deposition within non-MI.


  • Coronary flow velocity reserve in hypertensive patients with left ventricular systolic dysfunction

    by Valéria Fontenelle Angelim Pereira, Clovis De Carvalho Frimm, Ana Clara Tude Rodrigues, Jeane Mike Tsutsui, Mariana Cúri, Charles Mady, José Antonio Franchini Ramires

    Background: Hypertensive microvascular disease is speculated to be a limiting factor for the ability of left ventricular (LV) hypertrophy to maintain LV systolic function in systemic hypertension. The role of coronary reserve, which may be affected by microvascular disease, remains uncertain in the pathophysiology of hypertensive heart disease. Hypothesis: A progressive impairment of coronary flow velocity reserve (CFVR) according to the presence and severity of LV systolic dysfunction is anticipated to occur in hypertension. Methods: According to the absence or presence of LV dysfunction (LV fractional shortening ‐ FS% < 30), two groups of hypertensive patients were investigated: HP1 (n = 9, FS% = 36 ± 6) and HP2 (n = 13, FS% = 18 ± 6). Eight normal subjects (NL) served as controls (LVFS% = 35 ± 3). Doppler blood flow velocity was obtained from the left anterior descending coronary artery using transesophageal echocardiography before and during 6‐min continuous adenosine infusion (140 μg·kg‐1 ·min‐1 intravenous). The CFVR was calculated as the ratio of maximal to baseline peak diastolic flow velocities. Results: The comparison among NL, HP1, and HP2 groups showed statistically different (p < 0.05) mass index (101 ± 18, 172 ± 46, and 257 ± 54 g·m‐2), end‐systolic wall stress (76.9 ± 14.4, 78.4 ± 23.9, and 174.5 ± 43.0 103·dyn·cm‐2), and CFVR (3.5 ± 0.6, 3.2 ± 0.4, and 2.6 ± 0.8), respectively. The CFVR correlated significantly and directly with LVFS% (r = 0.40) and correlated inversely with both mass index (r = −0.54) and end‐systolic stress (r = −0.40). Conclusions: These results indicate that CFVR impairment is weakly related to LV dysfunction in hypertension.


  • Open Access

    Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form

    by Barbara Maria Ianni, Edmundo Arteaga, Clovis de Carvalho Frimm, Antonio Carlos Pereira Barretto, Charles Mady

    OBJECTIVE: To identify and associate potential electrocardiographic and echocardiographic changes in patients with the indeterminate form of Chagas' disease during long-term follow-up. METHODS: One hundred sixty patients underwent standard electrocardiography and two-dimensional guided M-mode echocardiography for left ventricular ejection fraction determination. Patients were followed up for 98.6±30.4 months, undergoing repeat electrocardiographic studies at 6-month intervals and echocardiographic studies at 12-month intervals. RESULTS: Based on the electrocardiographic findings, the patients were divided into group I, 125 patients (78.6%) with normal electrocardiograms throughout follow-up, and group II, 34 patients (21.3%) who developed electrocardiographic changes. Group II was further divided into group IIA (9 patients, 5.6%) with permanent electrocardiographic changes, group IIB (14 patients, 8.8%) with transitory electrocardiographic changes, and group IIC (11 patients, 6.9%) with changes appearing only on the final electrocardiogram. Left ventricular ejection fractions remained normal in the entire population studied and did not differ among groups. CONCLUSION: The indeterminate form of Chagas' disease clearly represents a benign condition with a favorable long-term prognosis. Although some patients develop electrocardiographic changes, left ventricular systolic function is well preserved.